These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 7964482)

  • 1. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
    Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS
    J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28.
    Peach RJ; Bajorath J; Naemura J; Leytze G; Greene J; Aruffo A; Linsley PS
    J Biol Chem; 1995 Sep; 270(36):21181-7. PubMed ID: 7545666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis.
    Truneh A; Reddy M; Ryan P; Lyn SD; Eichman C; Couez D; Hurle MR; Sekaly RP; Olive D; Sweet R
    Mol Immunol; 1996 Feb; 33(3):321-34. PubMed ID: 8649453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of conserved amino acids in murine B7-1IgV domain critical for CTLA4/CD28:B7 interaction by site-directed mutagenesis: a novel structural model of the binding site.
    Guo Y; Wu Y; Kong X; Liu Y
    Mol Immunol; 1998 Mar; 35(4):215-25. PubMed ID: 9736337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4 is a second receptor for the B cell activation antigen B7.
    Linsley PS; Brady W; Urnes M; Grosmaire LS; Damle NK; Ledbetter JA
    J Exp Med; 1991 Sep; 174(3):561-9. PubMed ID: 1714933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.
    Guo Y; Wu Y; Zhao M; Kong XP; Liu Y
    J Exp Med; 1995 Apr; 181(4):1345-55. PubMed ID: 7535334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
    J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
    Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
    Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and expression of feline CD28 and CTLA-4 cDNA.
    Choi IS; Hash SM; Collisson EW
    Vet Immunol Immunopathol; 2000 Aug; 76(1-2):45-59. PubMed ID: 10973685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase.
    Stein PH; Fraser JD; Weiss A
    Mol Cell Biol; 1994 May; 14(5):3392-402. PubMed ID: 8164687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of murine CTLA-4 and its role in modulating T cell responsiveness.
    Ostrov DA; Shi W; Schwartz JC; Almo SC; Nathenson SG
    Science; 2000 Oct; 290(5492):816-9. PubMed ID: 11052947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the site of interaction of CD28 with its counter-receptors CD80 and CD86 and correlation with function.
    Kariv I; Truneh A; Sweet RW
    J Immunol; 1996 Jul; 157(1):29-38. PubMed ID: 8683128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules.
    Linsley PS; Nadler SG; Bajorath J; Peach R; Leung HT; Rogers J; Bradshaw J; Stebbins M; Leytze G; Brady W
    J Biol Chem; 1995 Jun; 270(25):15417-24. PubMed ID: 7541042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion.
    Rennert P; Furlong K; Jellis C; Greenfield E; Freeman GJ; Ueda Y; Levine B; June CH; Gray GS
    Int Immunol; 1997 Jun; 9(6):805-13. PubMed ID: 9199963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2).
    Morton PA; Fu XT; Stewart JA; Giacoletto KS; White SL; Leysath CE; Evans RJ; Shieh JJ; Karr RW
    J Immunol; 1996 Feb; 156(3):1047-54. PubMed ID: 8557978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction properties of costimulatory molecules revisited.
    Collins AV; Brodie DW; Gilbert RJ; Iaboni A; Manso-Sancho R; Walse B; Stuart DI; van der Merwe PA; Davis SJ
    Immunity; 2002 Aug; 17(2):201-10. PubMed ID: 12196291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions.
    Greene JL; Leytze GM; Emswiler J; Peach R; Bajorath J; Cosand W; Linsley PS
    J Biol Chem; 1996 Oct; 271(43):26762-71. PubMed ID: 8900156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor.
    Razi-Wolf Z; Galvin F; Gray G; Reiser H
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11182-6. PubMed ID: 7504299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion.
    Wu Y; Guo Y; Huang A; Zheng P; Liu Y
    J Exp Med; 1997 Apr; 185(7):1327-35. PubMed ID: 9104819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cattle CTLA-4, CD28 and chicken CD28 bind CD86: MYPPPY is not conserved in cattle CD28.
    Parsons KR; Young JR; Collins BA; Howard CJ
    Immunogenetics; 1996; 43(6):388-91. PubMed ID: 8606060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.